Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis-Reference-Cited by-同舟云学术

Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis

Published:2020-06-06 Issue:10 Volume:267 Page:3008-3020
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

D’Amico Emanuele^ORCID,Zanghì Aurora,Sciandra Mariangela,Lanzillo Roberta,Callari Graziella,Cortese Antonio,Lus Giacomo,Lucchini Matteo,Buccafusca Maria,Bonavita Simona,Gallo Antonio,Curti Erica,Gajofatto Alberto,Signoriello Elisabetta,Bisecco Alvino,Gobbin Francesca,Ferrò Maria Teresa,Ferrazzano Gina,Sparaco Maddalena,Valentino Paola,Mirabella Massimiliano,Granella Franco,Bresciamorra Vincenzo,Grimaldi Luigi Maria Edoardo,Patti Francesco,Borriello Giovanna,Grossi Paola,Carotenuto Antonio,Siena Ernesto,Tsantes Elena,Giugno Alessia,Abbadessa Gian Marco,Chisari Clara Grazia,

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-020-09959-1.pdf

Reference28 articles.

1. Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple Sclerosis. N Engl J Med 378(2):169–180

2. D'Amico E, Leone C, Caserta C, Patti F (2015) Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal. Expert Rev Neurother 15(7):803–824

3. Ingwersen J, Aktas O, Hartung HP (2016) Advances in and algorithms for the treatment of relapsing-remitting multiple sclerosis. Neurothera J Am Soc Exp NeuroThera 13(1):47–57

4. Boster A, Nicholas J, Wu N, Yeh WS, Fay M, Edwards M et al (2017) Comparative effectiveness research of disease-modifying therapies for the management of multiple sclerosis: analysis of a large health insurance claims database. Neurol Ther 6(1):91–102

5. Confavreux C, O'Connor P, Comi G, Freedman MS, Miller AE, Olsson TP et al (2014) Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol 13(3):247–256

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge domain and trend of disease-modifying therapies for multiple sclerosis: A study based on CiteSpace;Heliyon;2024-03

2. Dimethyl Fumarate or Teriflunomide for Relapsing–Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing Studies;Neurotherapeutics;2023-09

3. Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis;European Journal of Neurology;2023-08-29

4. Personality Traits and Fatigue in Multiple Sclerosis: A Narrative Review;Journal of Clinical Medicine;2023-07-06

5. Dimethyl fumarate or teriflunomide for relapsing-remitting multiple sclerosis: a meta-analysis of post-marketing studies;2023-06-24